Examples of using Clinically relevant differences in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
There were no clinically relevant differences in the clearance of tigecycline between men and women.
multiple-doses of tadalafil, no clinically relevant differences in exposure were observed.
There were no clinically relevant differences in Cmax compared to healthy volunteers.
The analysis of the impact of NSCLC histology on overall survival demonstrated clinically relevant differences in survival according to histology, see table below.
There were no clinically relevant differences in systemic exposures between White,
A population pharmacokinetic analysis revealed no clinically relevant differences in pharmacokinetics between Caucasian and Black groups.
No clinically relevant differences in pharmacokinetics of rilpivirine have been observed between men and women.
Caucasian subjects no clinically relevant differences in pharmacokinetic parameters were observed.
There are no clinically relevant differences in pharmacokinetics between Caucasian and Asian subjects.
No clinically relevant differences in the pharmacokinetics of rilpivirine have been observed between men and women.
The results demonstrated no clinically relevant differences between sildenafil and placebo in time to limiting angina.
No clinically relevant differences in adverse reactions were observed between the overall dataset
Gender There were no clinically relevant differences in the clearance of tigecycline between men and women.
No clinically relevant differences in cobicistat pharmacokinetics were observed between subjects with moderate impairment and healthy subjects.
Elderly: There are no clinically relevant differences due to age in the pharmacokinetics of cinacalcet.
There were no clinically relevant differences in pharmacokinetic properties between young children,
There are no clinically relevant differences between genders in pharmacokinetic properties of insulin detemir.
There are no clinically relevant differences between genders in pharmacokinetic properties of Levemir.
There were no clinically relevant differences observed for the safety profile of ALIMTA within the histology subgroups.
There were no clinically relevant differences in pharmacokinetics and pharmacodynamics between male
There were no clinically relevant differences observed for the safety profile of ALIMTA plus cisplatin within the histology subgroups.
No clinically relevant differences in elvitegravir or cobicistat pharmacokinetics were observed between subjects with severe renal impairment and healthy subjects.
No clinically relevant differences were seen in the pharmacokinetics of repaglinide,
Gender: No clinically relevant differences in the pharmacokinetics of vildagliptin were observed between male
There were no clinically relevant differences in the safety population of the elderly subjects who received oseltamivir
There were no clinically relevant differences in incidence or severity of hypoglycaemia with exenatide compared to placebo, in combination with a thiazolidinedione,
No clinically relevant differences in the pharmacokinetics of insulin detemir are expected between healthy subjects and subjects with renal or hepatic impairment, based on the studies performed.
No clinically relevant differences in the pharmacokinetics of pirfenidone were observed in subjects with mild to severe renal impairment compared with subjects with normal renal function.
There are no clinically relevant differences in the pharmacokinetics of Ryzodeg between elderly and younger adult patients, between races
There were no other clinically relevant differences between two concurrent injections of Xiapex in the same hand and up to three